Gilead CEO Daniel O’Day saw another rise in his pay in 2024, reflecting the steadily upward trajectory of the company since ...

Gilead's HIV portfolio remains dominant but faces Medicare Part D pricing pressure, limiting future growth potential. New launches like Livdelzi provide growth opportunities but are unlikely to ...

Pic: Marc O'Sullivan Culture Date with Dublin 8 is back for its seventh year and this year coincides with the 250th anniversary of Daniel O’Connell’s birth. A special flagship concert is set ...

Frieren leads the pack with 29 total nominations across all categories, followed by Dan Da Dan with 22, Delicious in Dungeon and Kaiju No. 8 tied with 16 nominations each, and Solo Leveling and ...

Gilead stocks closing lower today after the Wall Street Journal reported the Department of Health and Human Services was considering federal funding cuts to domestic HIV prevention. Joining us now ...

Investing.com -- Gilead Sciences shares dropped more than 3% Wednesday following a Wall Street Journal report that the Health and Human Services Department is considering major cuts to federal ...

By Adam Goldman Reporting from Washington Dan Bongino, the F.B.I.’s deputy director, who rose to popularity as a conservative podcaster bashing Democrats and praising President Trump ...

Labour MP Dan Norris has been arrested on suspicion of rape and child sex offences. A Labour Party spokesperson said: "Dan Norris MP was immediately suspended by the Labour Party upon being ...

The move: Gilead Sciences dropped 2.52% in premarket trading, falling to $107.45 per share Wednesday morning. The biopharmaceutical company is up 19.34% for the year. Why: The stock's decline ...

Pharmaceutical stock Gilead Sciences Inc (NASDAQ:GILD) is down 2.6% at $107.34, after news that domestic HIV prevention is under review by the Trump administration, and the Health and Human ...

Roche executive Daniel O’Day is to take the helm at Gilead after John Milligan steps down as CEO at the end of this year, the company has announced. Currently CEO of Roche Pharmaceuticals since ...